GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.
- Published In:
- Metabolism: clinical and experimental, 61(10), 1422-34 (2012)
- Authors:
- Hendarto, Hari, Inoguchi, Toyoshi, Maeda, Yasutaka, Ikeda, Noriko, Zheng, Jing, Takei, Ryoko, Yokomizo, Hisashi, Hirata, Eiichi, Sonoda, Noriyuki, Takayanagi, Ryoichi
- Database ID:
- RPEP-01956
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01956APA
Hendarto, Hari; Inoguchi, Toyoshi; Maeda, Yasutaka; Ikeda, Noriko; Zheng, Jing; Takei, Ryoko; Yokomizo, Hisashi; Hirata, Eiichi; Sonoda, Noriyuki; Takayanagi, Ryoichi. (2012). GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.. Metabolism: clinical and experimental, 61(10), 1422-34. https://doi.org/10.1016/j.metabol.2012.03.002
MLA
Hendarto, Hari, et al. "GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.." Metabolism: clinical and experimental, 2012. https://doi.org/10.1016/j.metabol.2012.03.002
RethinkPeptides
RethinkPeptides Research Database. "GLP-1 analog liraglutide protects against oxidative stress a..." RPEP-01956. Retrieved from https://rethinkpeptides.com/research/hendarto-2012-glp1-analog-liraglutide-protects
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.